FKBP14 Overexpression Contributes to Osteosarcoma Carcinogenesis and Indicates Poor Survival Outcome

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 May 26

PMID 27223089

Citations 9

Authors

Zhongming Huang

Junhua Li

Shaohua Du

Yanghua Tang

Ligang Huang

Luwei Xiao

Peijian Tong

Affiliations

Soon will be listed here.

Abstract

The FK506-binding protein 14 (FKBP14) is a subfamily of immunophilins, has been implicated in various biochemical processes. However, its effects on the primary malignant bone tumor, osteosarcoma, are unclear. Here, we reported that FKBP14 may be an oncogene as it overexpressed in osteosarcoma tissues and cell lines, and FKBP14 expression was correlated with metastases, recurrence, tumor maximum diameter and poor survival time. FKBP14 was associated with the biological pathways including cell cycle, apoptosis and metastasis. Furthermore, we detected FKBP14 knockdown induced cell cycle arrest, apoptosis, invasion and adhesion in vitro. FKBP14 knockdown decreased the protein levels of PCNA, CDK1 and CCNB1 that promotes cell cycle, increased Bax, caspase-3 and caspase-7 protein involved in promoting cell apoptosis, and increased KIF4A expression as well as decreased SMC4 and TMEM33 proteins that contribute to cell invasion and adhesion. In addition, FKBP14 knockdown also caused a significant inhibition in tumor growth in vivo. Then, we found that the protein RhoA was identified as a binding partner of FKBP14. Taken together, FKBP14 may act as an oncogene in osteosarcoma via suppressing apoptosis and promoting invasion and adhesion in osteosarcoma carcinogenesis. FKBP14 may be a prognostic factor and potential target for osteosarcoma treatment.

Citing Articles

Clinical Significance and Potential Mechanisms of the RNA Methyltransferase KIAA1429 in Osteosarcoma.

Sun Y, Lei Y, Zeng J, Zhong L, Liu J, Man Y J Cancer. 2024; 15(1):126-139.

PMID: 38164289 PMC: 10751680. DOI: 10.7150/jca.86630.

Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma.

Wang L, Liu G, Bolor-Erdene E, Li Q, Mei Y, Zhou L Aging (Albany NY). 2021; 13(21):24050-24070.

PMID: 34775374 PMC: 8610135. DOI: 10.18632/aging.203585.

Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.

Gui T, Yao C, Jia B, Shen K PLoS One. 2021; 16(6):e0253136.

PMID: 34143800 PMC: 8213194. DOI: 10.1371/journal.pone.0253136.

FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers.

Xu H, Liu P, Yan Y, Fang K, Liang D, Hou X J Exp Clin Cancer Res. 2020; 39(1):44.

PMID: 32111229 PMC: 7048151. DOI: 10.1186/s13046-020-1541-0.

Prognostic Significance of FKBP14 in Gastric Cancer.

Ghoorun R, Wu X, Chen H, Ren D, Wu X Onco Targets Ther. 2020; 12:11567-11577.

PMID: 31920344 PMC: 6941606. DOI: 10.2147/OTT.S221943.

References

Baumann M, Giunta C, Krabichler B, Ruschendorf F, Zoppi N, Colombi M . Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet. 2012; 90(2):201-16. PMC: 3276673. DOI: 10.1016/j.ajhg.2011.12.004. View

Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E . High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008; 98(6):415-20. DOI: 10.1002/jso.21140. View

Spampanato C, de Maria S, Sarnataro M, Giordano E, Zanfardino M, Baiano S . Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression. Int J Oncol. 2011; 40(4):935-41. PMC: 3584570. DOI: 10.3892/ijo.2011.1273. View

Han J, Tian R, Yong B, Luo C, Tan P, Shen J . Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients. Biochem Biophys Res Commun. 2013; 435(3):493-500. DOI: 10.1016/j.bbrc.2013.05.019. View

Li X, Peng S . Identification of metastasis-associated genes in colorectal cancer through an integrated genomic and transcriptomic analysis. Chin J Cancer Res. 2014; 25(6):623-36. PMC: 3872552. DOI: 10.3978/j.issn.1000-9604.2013.11.01. View

Meng Q, Zheng M, Liu H, Song C, Zhang W, Yan J . SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Mol Cell Biochem. 2012; 373(1-2):201-10. DOI: 10.1007/s11010-012-1491-8. View

Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H . MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. 2013; 35(3):2537-48. DOI: 10.1007/s13277-013-1335-5. View

Mirabello L, Troisi R, Savage S . Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115(7):1531-43. PMC: 2813207. DOI: 10.1002/cncr.24121. View

Valastyan S, Weinberg R . Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147(2):275-92. PMC: 3261217. DOI: 10.1016/j.cell.2011.09.024. View

10.

Hu Y, Chen H, Yu C, Xu J, Wang J, Qian J . A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget. 2014; 5(8):2230-42. PMC: 4039159. DOI: 10.18632/oncotarget.1895. View

11.

Tsai H, Su H, Huang C, Fong Y, Hsu C, Tang C . CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014; 5(11):3800-12. PMC: 4116521. DOI: 10.18632/oncotarget.1998. View

12.

Barik S . Immunophilins: for the love of proteins. Cell Mol Life Sci. 2006; 63(24):2889-900. PMC: 11136219. DOI: 10.1007/s00018-006-6215-3. View

13.

Fromigue O, Hamidouche Z, Marie P . Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 2008; 283(45):30549-56. PMC: 2662148. DOI: 10.1074/jbc.M801436200. View

14.

Hughes D . Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv. 2009; 6(12):1311-21. PMC: 4163784. DOI: 10.1517/17425240903280422. View

15.

van de Hoef D, Hughes J, Livne-Bar I, Garza D, Konsolaki M, Boulianne G . Identifying genes that interact with Drosophila presenilin and amyloid precursor protein. Genesis. 2009; 47(4):246-60. DOI: 10.1002/dvg.20485. View

16.

Romano S, DAngelillo A, Romano M . Pleiotropic roles in cancer biology for multifaceted proteins FKBPs. Biochim Biophys Acta. 2015; 1850(10):2061-8. DOI: 10.1016/j.bbagen.2015.01.004. View

17.

Gao J, Sai N, Wang C, Sheng X, Shao Q, Zhou C . Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumour Biol. 2010; 32(1):53-61. DOI: 10.1007/s13277-010-0090-0. View

18.

Storer C, Dickey C, Galigniana M, Rein T, Cox M . FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab. 2011; 22(12):481-90. PMC: 3229651. DOI: 10.1016/j.tem.2011.08.001. View

19.

Taniwaki M, Takano A, Ishikawa N, Yasui W, Inai K, Nishimura H . Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res. 2007; 13(22 Pt 1):6624-31. DOI: 10.1158/1078-0432.CCR-07-1328. View

20.

Klein M, Siegal G . Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006; 125(4):555-81. DOI: 10.1309/UC6K-QHLD-9LV2-KENN. View